(1 - 11 von 12
)
Biocartis Completes €34,5 Million ($44,5 Million) Series D Fund...
www.finanznachrichten.de
... Group(TM), Korys (investment holding of the Colruyt family), Philips, Johnson & Johnson Development Corporation (JJDC), the family office of Dr Paul Janssen, Luc Verelst
Biocartis completes third round funding - Switzerland’s highest VC...
www.seca.ch
... the Wellcome Trust Ltd , Korys Management, Valiance, Biovest, Mr Luc Verelst of IHL SA, PMV, New Rhein Healthcare LLC, certain members ...
Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund...
www.finanznachrichten.de
LAUSANNE, Switzerland, November 17, PRNewswire/ -- Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed...
Biocartis Completes EUR 71 Million Series C
www.vcnewsdaily.com
... IHL SA (Luc Verelst), PMV, New Rhein Healthcare, certain members of the Biocartis senior management team and the family office of founder ...
sortiert nach Relevanz / Datum